Florian Brand
Fortune : 599 468 $ au 31/05/2026
Fortune : 599 468 $ au 31/05/2026
Florian Brand is the founder of ATAI Life Sciences AG, founded in 2018, holding the title of Chief Executive Officer.
Mr. Brand is also the founder of EmpathBio, Inc.,IntroSpect Digital Therapeutics, Inc.,Atai Therapeutics, Inc...
Mr. Brand is a Director at DemeRx, Inc., Innoplexus AG, Perception Neuroscience, Inc., COMPASS Pathfinder Holdings Ltd., GABA Therapeutics, Inc., EntheogeniX Biosciences, Inc., and Recognify Life Sciences, Inc. Former positions include Chief Executive Officer at Perception Neuroscience, Inc. from 2018 to 2019, Managing Director at Springlane GmbH from 2015 to 2018, and Non-Executive Director at Compass Pathways Plc from 2020 to 2021.
Education includes undergraduate studies at Ludwig-Maximilians-Universität München and graduate studies at ESCP Europe Campus London.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,04 % | 15/09/2025 | 132 333 ( 0,04 % ) | 599 468 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Directeur Général | 01/01/2018 |
GABA Therapeutics, Inc.
GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur/Membre du Conseil | - |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Directeur/Membre du Conseil | - |
EntheogeniX Biosciences, Inc.
EntheogeniX Biosciences, Inc. BiotechnologyHealth Technology Develops medicines for mental health diseases | Directeur/Membre du Conseil | - |
Innoplexus AG
Innoplexus AG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Directeur/Membre du Conseil | - |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 01/03/2019 |
Viridia Life Sciences, Inc.
Viridia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Fondateur | - |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur/Membre du Conseil | - |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Springlane GmbH
Springlane GmbH Catalog/Specialty DistributionRetail Trade Operates an online food and kitchenware shopping platform | Retail Trade |
ESCP Europe Campus London
ESCP Europe Campus London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoplexus AG
Innoplexus AG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Health Technology |
Compass Pathways Plc
Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Health Services |
COMPASS Pathfinder Holdings Ltd.
COMPASS Pathfinder Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
GABA Therapeutics, Inc.
GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
EntheogeniX Biosciences, Inc.
EntheogeniX Biosciences, Inc. BiotechnologyHealth Technology Develops medicines for mental health diseases | Health Technology |
EmpathBio, Inc.
EmpathBio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
IntroSpect Digital Therapeutics, Inc.
IntroSpect Digital Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for mental health care and support | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Commercial Services |
Viridia Life Sciences, Inc.
Viridia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national